Screener
UroGen Pharma URGN Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 597 | 637 |
| Restricted deposit | 178 | 177 |
| Finance lease right-of-use assets | 4,818 | 5,376 |
| Operating lease right-of-use assets | 2,810 | 3,080 |
| Other non-current assets | 8,761 | 5,161 |
| Total assets | $252,590 | $200,455 |
| Liabilities and Shareholders' Deficit | ||
| Current liabilities: |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's operating lease ROU assets?
- UroGen Pharma (URGN) reported operating lease ROU assets of $2.81M in Q2 2026.
- What is the long-term trend for UroGen Pharma's operating lease ROU assets?
- Over 4 years (2020 to 2025), UroGen Pharma's operating lease ROU assets has grown at a 9.3% compound annual growth rate (CAGR), from $2.16M to $3.08M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about UroGen Pharma's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude